Form 4: ALX Oncology CEO Jason Lettmann Acquires 125,000 Employee Stock Options
SEC Form 4 Filing
ALX Oncology Holdings CEO Jason Lettmann reports acquisition of 125,000 employee stock options on April 11, 2025.
Summary
- Jason Lettmann, CEO of ALX Oncology Holdings Inc., filed a Form 4 on April 15, 2025, reporting a transaction.
- On April 11, 2025, Lettmann acquired 125,000 employee stock options with an exercise price of $0.49.
- These options vest on April 11, 2026, and expire on April 11, 2035.
- Following the transaction, Lettmann beneficially owns 125,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard stock option grant. It's neither overwhelmingly positive nor negative.
Positives
- The acquisition of stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation in the biotechnology industry, used to align management's interests with those of shareholders.
- The vesting schedule of one year is fairly standard.
- Comparable companies such as Gilead, Amgen, and Regeneron also utilize stock options as part of their executive compensation packages.
Stakeholder Impact
- The stock option grant could potentially incentivize the CEO to improve company performance, benefiting shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/11/2025 | Date of the transaction: Jason Lettmann acquired 125,000 employee stock options. |
| 04/11/2026 | Vesting date for the acquired stock options. |
| 04/11/2035 | Expiration date for the acquired stock options. |
| 04/15/2025 | Date the Form 4 was filed. |
Keywords
ALX Oncology, Jason Lettmann, stock options, Form 4, insider trading, derivative securities, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.